Korsana Biosciences, Inc. (NASDAQ:KRSA)
| Market Cap | 149.36M+78.7% |
| Revenue (ttm) | 1.90M-12.6% |
| Net Income | -6.71M-244.7% |
| EPS | -1.43-129.3% |
| Shares Out | 4.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 113,783 |
| Open | 25.22 |
| Previous Close | 24.56 |
| Day's Range | 25.22 - 32.27 |
| 52-Week Range | 7.19 - 59.36 |
| Beta | 1.75 |
| Analysts | Buy |
| Price Target | 55.00(+72.39%) |
| Earnings Date | Nov 11, 2026 |
About KRSA
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
$KRSA stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in KRSA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by KRSA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
KRSA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New KRSA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to KRSA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in KRSA
| ETF | Est. Holding Size |
|---|---|
| ONEQFidelity Nasdaq Composite Index ETF | $74.81K |
| DFSUDimensional - US Sustainability Core 1 ETF | $11.64K |
| DFACDimensional - US Core Equity 2 ETF | $7.68K |
| DCORDimensional - US Core Equity 1 ETF | $2.62K |
Estimated from each fund’s disclosed top holdings × AUM
KRSA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from KRSA’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.